BIOMAT Database Logo BIOMAT Database Logo

Testing of anti-HIV antibodies in saliva. 1994

O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin

UI MeSH Term Description Entries
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D012471 Salivary Proteins and Peptides Proteins and peptides found in SALIVA and the SALIVARY GLANDS. Some salivary proteins such as ALPHA-AMYLASES are enzymes, but their composition varies in different individuals. Salivary Gland Protein,Salivary Gland Proteins,Salivary Peptide,Salivary Protein,Salivary Proteins,Salivary Peptides,Gland Protein, Salivary,Peptide, Salivary,Protein, Salivary,Protein, Salivary Gland
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015492 AIDS Serodiagnosis Immunologic tests for identification of HIV (HTLV-III/LAV) antibodies. They include assays for HIV SEROPOSITIVITY and HIV SERONEGATIVITY that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of AIDS or AIDS-RELATED COMPLEX. AIDS Serology,HIV Serodiagnosis,HTLV-III Serodiagnosis,HTLV-III Serology,Serodiagnosis, AIDS,Serodiagnosis, HIV,Serodiagnosis, HTLV-III,Serology, AIDS,Serology, HTLV-III,AIDS Serodiagnoses,HIV Serodiagnoses,HTLV III Serodiagnosis,HTLV III Serology,HTLV-III Serodiagnoses,Serodiagnoses, AIDS,Serodiagnoses, HIV,Serodiagnoses, HTLV-III,Serodiagnosis, HTLV III,Serology, HTLV III

Related Publications

O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Detection of anti-HIV antibodies in saliva.
April 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Testing of saliva for antibodies to HIV-1.
May 1991, AIDS (London, England),
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Saliva and HIV testing.
February 1993, Lancet (London, England),
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Saliva and HIV testing.
February 1993, Lancet (London, England),
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Antibodies to HIV in saliva.
April 1989, The New England journal of medicine,
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Anti-mycobacterial antibodies in saliva.
December 1986, Leprosy review,
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Testing for HIV antibody in saliva and HIV-testing centres.
December 1994, AIDS (London, England),
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
[AIDS. HIV antibodies detected in saliva].
February 1989, Fortschritte der Medizin,
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
HIV surveillance by testing saliva.
October 1988, AIDS (London, England),
O Chassany, and J F Bergmann, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Anti-C3 antibodies in neonatal saliva.
September 1975, Nature,
Copied contents to your clipboard!